SFX by Ex Libris Inc.

Title:	Second-generation antipsychotics and pregnancy complications
Source:	European Journal of Clinical Pharmacology [0031-6970] Ellfolk, Maria yr:2019

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	"Antipsychotics during pregnancy and increased risk of congenital malformation in offspring: toward a systematic use of real-world data." The Lancet Regional Health - Europe 11: 100257-100257.
description	2.	"Use of Antipsychotic Drugs During Pregnancy." Current treatment options in psychiatry. 6.1: 17-31.
description	3.	Verrotti, A. "Potential Teratogenic Effects of Clomiphene Citrate." Drug Safety 40.9 (2017): 761-769.
description	4.	"Second-generation antipsychotics and pregnancy complications: the impact of confounding by indication." European journal of clinical pharmacology. 77.3: 439-440.
description	5.	"Antipsychotic Use During Pregnancy Isn't Harmful to Children." JAMA : the journal of the American Medical Association. 326.17: 1666-1666.
description	6.	Cornelis, Marilyn C. "The Impact of Caffeine and Coffee on Human Health." Nutrients 11.2 (2019): 416-416.
description	7.	Park, Y. "Antipsychotic Medication Use Among Publicly Insured Pregnant Women in the United States." Psychiatric Services 68.11 (2017): 1112-1119.
description	8.	Cristina Ruan Ferreira de, Araújo, C. "Use of Medicinal Plants with Teratogenic and Abortive Effects by Pregnant Women in a City in Northeastern Brazil." Revista brasileira de ginecologia e obstetrícia 38.3 (2016): 127-131.
description	9.	Schaefer, C. "Atypical Antipsychotic Drugs and Pregnancy Outcome." Journal of clinical psychopharmacology 33.4 (2013): 453-462.
description	10.	McCauley-Elsom, K. "Antipsychotics in pregnancy." Journal of psychiatric and mental health nursing 17.2 (2010): 97-104.
description	11.	"Antipsychotic Use in Pregnancy: Patient Mental Health Challenges, Teratogenicity, Pregnancy Complications, and Postnatal Risks." Neurology international. 14.1: 62-74.
description	12.	"Gestational and Neurodevelopmental Outcomes Associated With Antipsychotic Drug Exposure During Pregnancy." The journal of clinical psychiatry. 82.5.
description	13.	de Melo Pereira, Gilberto V V. "Chemical composition and health properties of coffee and coffee by-products." Adv Food Nutr Res 91 (2020): 65-96.
description	14.	Loftfield, E. "The Alleged Health-Protective Effects of Coffee-Reply." JAMA Internal Medicine 178.12 (2018): 1726-1727.
description	15.	Engeland, A. "Preterm births and use of medication in early adulthood: a population-based registry study." Pharmacoepidemiology and drug safety 26.7 (2017): 742-751.
description	16.	Medeiros, MA. "Teratogenic effects of Prosopis juliflora in rats and analysis of the toxicity of the pods." Pesquisa veterinária brasileira 34.11 (2014): 1089-1093.
description	17.	Chaput, J. "Lack of sleep as a contributor to obesity in adolescents: impacts on eating and activity behaviors." International Journal of Behavioral Nutrition and Physical Activity 13.1 (2016): 103-103.
description	18.	"Drugs and pregnancy: human teratogenesis and related problems." Archives of disease in childhood 58.10 (1983): 843-843.
description	19.	Sadowski, A. "Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study." BMJ open 3.7 (2013).
description	20.	Costa, Tiago M. "Medicinal plants with teratogenic potential: current considerations." Brazilian Journal of Pharmaceutical Sciences 48.3 (2012): 427-433.